remdesivir inhibits the coronavirus rna dependent polymerase rdrp |
||||||||||||||||||||||||||||||||||||||||
| navigate by keyword : acute analog coronavirus covid19 dependent drug enzyme epidemic illness molecule nucleotide pandemic polymerase promising protein remdesivir replication respiratory rna sarscov2 sudden syndrome target |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| The nucleotide analog remdesivir blocks the SARS-CoV-2 RNA dependent RNA polymerase and is a promising drug for the treatment of COVID-19. RdRp is an enzyme that catalyzes the replication of RNA from an RNA template. PDB entry 7BTF |
||||||||||||||||||||||||||||||||||||||||
|
Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners. |
||||||||||||||||||||||||||||||||||||||||
